Prospective comparison of hybrid 68Ga-PSMA PET/CT and PET/MR in patients with biochemically recurrent prostate cancer

被引：0
|
作者：
Jentjens, S. [1 ]
Mai, C. [1 ]
De Coster, L. [2 ]
Bidakhvidi, N. Ahmadi [1 ]
Mertens, N. [1 ]
Everaerts, W. [1 ]
Joniau, S. [1 ]
Oyen, R. [1 ]
Van Laere, K. [1 ]
Goffin, K. [1 ]
机构：
[1] Univ Hosp Leuven, Leuven, Belgium
[2] Europe Hosp, Brussels, Belgium
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0135
引用
收藏
页码：S445 / S445
页数：1
相关论文
共 50 条
  • [31] Comparison of 68Ga-PSMA PET/CT and multiparametric MRI for staging of high-risk prostate cancer68Ga-PSMA PET and MRI in prostate cancer
    Tulsyan, Shruti
    Das, Chandan J.
    Tripathi, Madhavi
    Seth, Amlesh
    Kumar, Rajeev
    Bal, Chandrasekhar
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (12) : 1094 - 1102
  • [32] 68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
    Ceci, Francesco
    Uprimny, Christian
    Nilica, Bernhard
    Geraldo, Llanos
    Kendler, Dorota
    Kroiss, Alexander
    Bektic, Jasmin
    Horninger, Wolfgang
    Lukas, Peter
    Decristoforo, Clemens
    Castellucci, Paolo
    Fanti, Stefano
    Virgolini, Irene J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (08) : 1284 - 1294
  • [33] Clinical value of negative 68Ga-PSMA PET/CT in the management of biochemical recurrent prostate cancer patients
    M Celli
    U De Giorgi
    P Caroli
    V Di Iorio
    L Fantini
    V Rossetti
    F Foca
    S Nicolini
    M Giganti
    G Paganelli
    F Matteucci
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 87 - 94
  • [34] Reply: "The Impact of 68Ga-PSMA PET/CT and PET/MRI on the Management of Prostate Cancer"
    Hoffmann, Manuela A.
    Wieler, Helmut J.
    Baues, Christian
    Kuntz, Nicholas J.
    Richardsen, Ines
    Schreckenberger, Mathias
    UROLOGY, 2019, 131 : 262 - 263
  • [35] LCerebellar Metastases From Prostate Cancer on 68Ga-PSMA PET/CT
    Chan, Mico
    Hsiao, Edward
    Turner, Jennifer
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (03) : 193 - 194
  • [36] The use of 68Ga-PSMA PET/CT following radical prostatectomy for suspected biochemically recurrent disease
    Raveenthiran, S.
    Yaxley, J.
    Yaxley, A.
    Coughlin, G.
    Yaxley, W.
    Gianduzzo, T.
    Kua, B.
    Pokorny, M.
    McEwan, L.
    Wong, D.
    BJU INTERNATIONAL, 2019, 123 : 24 - 25
  • [37] Impact of 68Ga-PSMA PET/CT on Survival and Management in Prostate Cancer
    Algin, Efnan
    Okudan, Berna
    Acikgoz, Yusuf
    Sayan, Haluk
    Bal, Oznur
    Seven, Bedri
    CURRENT MEDICAL IMAGING, 2024, 20
  • [38] 68Ga-PSMA PET/CT; current impact on management in prostate cancer
    Intema, F.
    Kooistra, A.
    Lont, A. P.
    Hendriks, L. P. J.
    Esser, J. P.
    Lange, R.
    de Klerk, J. M. H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S707 - S707
  • [39] Primary staging of prostate cancer using 68Ga-PSMA PET/CT
    Graziani, T.
    Scarlattei, M.
    Baldari, G.
    Migliari, S.
    Sammartano, A.
    Gasparro, D.
    Maestroni, U.
    Ruffini, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S599 - S600
  • [40] Asymptomatic Prostate Cancer Brain Metastases on 68Ga-PSMA PET/CT
    Yin, Charlotte
    Ho, Bao
    Chan, Lyn
    Emmett, Louise
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (06) : E382 - E384
12345